Advises on managed care regulation across commercial, Medicare Advantage, Part D, and Medicaid programs

Represents companies across the drug supply chain to negotiate complex and innovative commercial partnerships

Structures joint ventures and value-based reimbursement arrangements between health plans and providers

Leads managed care M&A and secures regulatory approvals from CMS and state agencies

Represents clients in risk adjustment investigations, qui tam actions, and coverage litigation

Advises health insurers, HMOs, provider organizations, and private equity funds on complex regulatory matters and healthcare M&A  

Counsels clients on Medicare Advantage, Medicare Part D, and Medicaid managed care programs  

Helps innovative companies navigate state risk-bearing regulations and structure transactions involving federal and state healthcare programs  

Advises healthcare companies on District of Columbia certificate of need (CON) laws, including CON approvals for new services, ownership changes, and facility closures

Matt Perreault advises healthcare organizations on complex transactions, sophisticated managed care arrangements, and related fraud and abuse matters. He represents accountable care organizations (ACOs); diverse provider, risk intermediary, care management and provider enablement organizations; health plans; and investors on a wide range of value-based care agreements, including shared savings, bundled payments, downside risk and capitation arrangements.

Matt serves as a strategic advisor to ACOs, independent physician associates (IPAs), managed care networks, integrated delivery networks and other healthcare providers, including hospitals and health systems, specialty providers, physician practices and innovative primary care organizations, on acquisitions, affiliations, reorganizations and other transactions. He also provides guidance on regulatory and fraud and abuse matters related to these transactions and contractual arrangements, including the physician self-referral law (Stark Law), the Anti-Kickback Statute, and general healthcare law and compliance matters.

Prior to joining McDermott Will & Schulte, Matt was deputy general counsel of a large national private health system, where he served as the lead lawyer for its managed care network, multi-specialty physician practice and hospital physician contracting throughout the system.

Mimi Alexandre counsels clients across the healthcare industry with a particular focus on entities in the managed care arena. Mimi routinely works with health plans, health maintenance organizations, private equity funds and vendors, helping them navigate complex regulatory schemes and facilitate business objectives.

Mimi has deep familiarity with and significant experience in government programs, including Medicare Advantage and Part D. She leverages this knowledge to provide risk assessments and practical advice. Mimi also routinely negotiates complex agreements with providers, pharmaceutical benefits managers and risk adjustment vendors. As the managed care landscape shifts, Mimi has gained significant experience evaluating the need for risk-bearing licenses and assisting in the formation of value-based contracting arrangements.

Mimi regularly brings her regulatory knowledge to bear on transactions involving plans, providers, intermediaries and vendors. In this capacity, Mimi evaluates regulatory and business risks for buyers and investors and negotiates deal documents accordingly.

Jiayan Chen is an industry leader on matters relating to health data, technology and research. She represents clients on regulatory and compliance matters, commercial transactions, and investments and acquisitions that require deep knowledge of privacy, data strategies, artificial intelligence (AI) and other healthcare technologies, or research compliance. Clients turn to Jiayan for her practical, industry-informed guidance as they seek to develop, improve, deploy, or acquire solutions or businesses that harness the power of data or technology. Jiayan has extensive experience advising on investments and acquisitions in the life sciences sector, particularly with respect to businesses that conduct clinical research or offer solutions designed to accelerate research or research recruitment. Her practice includes working with patient safety organizations (PSOs) on listing applications, compliance, and strategies for appropriately creating and sharing patient safety work product.

Jiayan’s subject matter and industry insights come from advising a broad range of clients, including AI and other healthcare technology companies; data companies; hospitals and health systems; academic medical centers; genetics companies; digital health companies; PSOs; drug, device, and biotech companies; private equity funds; and platform companies.

Jiayan regularly counsels clients on data privacy requirements under US federal and state privacy law, including the Health Insurance Portability and Accountability Act (HIPAA) and various state genetic, health information, and consumer privacy laws. She works with clients on mapping and implementing data use and sharing strategies with appropriate data governance and programmatic safeguards. Well before the proliferation of generative AI, Jiayan was working with AI developers and deployers on compliance with privacy and research laws, efforts to leverage data to train and validate AI tools, and transactions involving the licensing of AI tools and AI-enabled platforms. These days, Jiayan also guides clients in developing AI governance and advises on proposed regulatory and legislative changes impacting AI.

Jiayan represents clients on a wide array of matters related to biomedical research, including negotiating the full range of agreements impacting research, building research compliance infrastructure, preparing protocols and informed consent and authorizations, and conducting transactions involving research site networks, providers of research solutions and other stakeholders in the biomedical research space. Jiayan’s regulatory practice includes counseling clients on state and federal “sunshine” and gift ban laws. She analyzes proposed arrangements and corporate organizational structures to identify and inform reporting obligations, and helps clients develop compliance mechanisms for managing their reporting obligations.

Gary Scott Davis, PA, advises clients on issues concerning managed care, including emerging health benefit plans, strategic restructurings and reorganizations, dispositions, mergers, joint ventures and contractual matters. The Florida Bar Board of Legal Specialization and Education recognizes Gary as a Board Certified Health Law Attorney.

Gary is a nationally recognized speaker on organizational and reimbursement transactions relating to managed health care, health care contracting and joint ventures. He is also a published author of numerous writings on managed care.

Gary has served as an adjunct lecturer of health care law for the Graduate School of Business Administration (MBA Programs for Executives), University of Miami and on the Advisory Board and faculty of the Nova Southeastern University Institute of Continuing Education for Health Care Professionals.

Brad Dennis represents a broad range of healthcare organizations, with a particular focus on complex transactions involving health systems, health plans, innovative joint ventures, and value-based care models. He works with health systems, health plans, investors, and other providers to design and execute deals that advance clinical, financial, and strategic objectives in the evolving healthcare ecosystem.

In the hospital sector, Brad advises nonprofit and for-profit health systems and academic medical centers on acquisitions, divestitures, affiliations, and joint ventures. He is known for balancing governance, regulatory, and business considerations in ways that keep deals moving and create durable partnerships.

Brad centers a significant portion of his practice  on healthcare joint ventures. He has extensive experience structuring and negotiating hospital service line partnerships, joint ventures, and other multiparty collaborations involving health systems, health plans, and for-profit platforms. He is recognized for navigating complex investment, governance, and regulatory issues to align diverse stakeholders and support growth.

In the managed care space, Brad advises on health plan acquisitions; joint ventures; and the development of provider-sponsored health plans, risk-bearing entities, and value-based care “enabler” models. He is at the forefront of transactions that bring providers and payers together, helping organizations evaluate risk, align incentives, and advance sustainable value-based strategies.

Clients rely on Brad for his practical decision-making, deep industry insight, and ability to deliver innovative solutions that bridge business and clinical priorities. He is a trusted advisor in the boardroom and at the deal table, helping organizations make confident decisions in transactions that reshape markets and define the next generation of healthcare models.

With a focus on complex transactions and regulatory compliance, Patrick Healy represents a wide range of healthcare industry participants, including non-profit and for-profit health systems, academic medical centers, physician organizations, post-acute providers and health plans. He works alongside his clients to execute their most critical transactions and strategic initiatives, leveraging corporate and healthcare regulatory expertise to drive an efficient and client-oriented approach to achieving his client’s business goals. Patrick has helped his clients navigate and successfully close more than 100 healthcare transactions with a focus on mergers, acquisitions, strategic affiliations, classic and contractual joint ventures and joint operating arrangements.

Patrick also routinely advises clients on a variety of transactional and regulatory matters related to value-based payment programs and delivery systems, leveraging his health economics and healthcare policy backgrounds in doing so. He assists accountable care organizations (Medicare, Medicaid, commercial) and other clinically integrated networks with formation, regulatory compliance, physician and management company joint ventures and participating provider relationships. Patrick advises hospitals and physician groups on their participation in Medicare, Medicaid, commercial bundled-payment and population health payment programs.

Patrick also represents several medication-assisted treatment (MAT) providers and other substance use disorder (SUD) treatment providers with respect to growth strategy and transactions and regulatory compliance, including telehealth providers and portfolio companies operating on a physician practice management platform.

Prior to practicing law, Patrick obtained a Masters in Health Economics from the London School of Economics and was the senior research assistant for health policy in the Economic Studies Program at The Brookings Institution—a Washington, D.C. think tank consistently ranked as the most influential in the world.

Leads complex healthcare transactions, including mergers and acquisitions, joint ventures, affiliations, management arrangements, and MSO structures

Advises on health information privacy, data use, cybersecurity, and regulatory compliance

Guides digital health, AI, and data-driven initiatives at the intersection of corporate structure, healthcare regulation, and data governance

Counsels healthcare and life sciences clients on government investigations, regulatory compliance, and compliance program development  

Represents clients in False Claims Act qui tam matters, government audits, civil monetary penalty and exclusion investigations, and CMS suspension and revocation actions  

Advises on the Anti-Kickback Statute and Stark Law, and on Medicare and Medicaid coverage and payment rules  

Negotiates and implements corporate integrity agreements and makes government self-disclosures